• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名接受抗TNF治疗的类风湿关节炎患者发生肠坏死。

Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment.

作者信息

Ruppert M, De Clerck L, van Offel J, Hubens G, Balliu L, Vaneerdeweg W

机构信息

Department of Abdominal Surgery, University of Antwerp, Antwerp, Belgium.

出版信息

Acta Chir Belg. 2006 Mar-Apr;106(2):225-7. doi: 10.1080/00015458.2006.11679877.

DOI:10.1080/00015458.2006.11679877
PMID:16761484
Abstract

Vasculitis leading to intestinal necrosis is a rare complication of rheumatoid arthritis. The introduction of anti-TNF treatment for methotrexate-resistant cases improved disease-control substantially in these often more aggresive forms of rheumatoid arthritis. As far as we know only two cases of severe vasculitis following anti-TNF treatment have been reported. We describe a 45-year old female patient with severe rheumatoid arthritis, who presented with an epileptic insult, renal failure and a quickly deteriorating general condition due to intestinal vasculitis, while she had been receiving anti-TNF treatment for 6 months.

摘要

导致肠道坏死的血管炎是类风湿关节炎的一种罕见并发症。对于甲氨蝶呤耐药的病例,采用抗TNF治疗可显著改善这些通常更为侵袭性的类风湿关节炎的疾病控制情况。据我们所知,仅有两例抗TNF治疗后发生严重血管炎的病例报告。我们描述了一名45岁的重症类风湿关节炎女性患者,在接受抗TNF治疗6个月时,因肠道血管炎出现癫痫发作、肾衰竭及全身状况迅速恶化。

相似文献

1
Intestinal necrosis in a patient with rheumatoid arthritis receiving anti-TNF treatment.一名接受抗TNF治疗的类风湿关节炎患者发生肠坏死。
Acta Chir Belg. 2006 Mar-Apr;106(2):225-7. doi: 10.1080/00015458.2006.11679877.
2
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis?抗肿瘤坏死因子-α应该作为类风湿性血管炎的首选治疗方法吗?
J Rheumatol. 2006 Feb;33(2):433; author reply 433-4.
3
Comparison of the clinical characteristics of vasculitis occurring during anti-tumor necrosis factor treatment or not in rheumatoid arthritis patients. A systematic review of 2707 patients, 18 vasculitis.类风湿关节炎患者中接受或未接受抗肿瘤坏死因子治疗时发生血管炎的临床特征比较。对2707例患者进行的系统评价,其中有18例血管炎。
Clin Exp Rheumatol. 2008 May-Jun;26(3 Suppl 49):S23-9.
4
Improved rheumatoid digital vasculitis in a patient treated with TNFalpha agent blocking (infliximab).使用肿瘤坏死因子α阻断剂(英夫利昔单抗)治疗的患者类风湿性手指血管炎得到改善。
Rheumatol Int. 2008 Oct;28(12):1253-5. doi: 10.1007/s00296-008-0592-x. Epub 2008 May 21.
5
Rheumatoid vasculitis treated with infliximab.用英夫利昔单抗治疗的类风湿性血管炎。
J Rheumatol. 2005 Aug;32(8):1607-9.
6
Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B.英夫利昔单抗在一名类风湿性关节炎合并慢性乙型肝炎患者中的应用。
Rev Bras Reumatol. 2012 Aug;52(4):653-5.
7
Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.英夫利昔单抗与甲氨蝶呤治疗类风湿关节炎。类风湿关节炎联合治疗抗肿瘤坏死因子试验研究组。
N Engl J Med. 2000 Nov 30;343(22):1594-602. doi: 10.1056/NEJM200011303432202.
8
Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.接受抗TNF-α药物治疗的类风湿关节炎患者发生带状疱疹的风险。
JAMA. 2009 Feb 18;301(7):737-44. doi: 10.1001/jama.2009.146.
9
Development of myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis in a patient receiving treatment with anti-tumor necrosis factor-α.在接受抗肿瘤坏死因子-α治疗的患者中,髓过氧化物酶-抗中性粒细胞胞质抗体相关的肾血管炎的发展。
Mod Rheumatol. 2010 Dec;20(6):602-5. doi: 10.1007/s10165-010-0339-x. Epub 2010 Aug 4.
10
Infliximab treatment of rheumatoid arthritis.英夫利昔单抗治疗类风湿关节炎。
Rheum Dis Clin North Am. 2004 May;30(2):329-47, vii. doi: 10.1016/j.rdc.2004.01.009.

引用本文的文献

1
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.《2007年关于治疗风湿性疾病生物制剂的更新共识声明》
Ann Rheum Dis. 2007 Nov;66 Suppl 3(Suppl 3):iii2-22. doi: 10.1136/ard.2007.081430.